These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1084 related items for PubMed ID: 29849132

  • 1. Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer.
    Liu HN, Guo NN, Guo WW, Huang-Fu MY, Vakili MR, Chen JJ, Xu WH, Wei QC, Han M, Lavasanifar A, Gao JQ.
    Acta Pharmacol Sin; 2018 Oct; 39(10):1681-1692. PubMed ID: 29849132
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
    Zhong Y, Zhang J, Cheng R, Deng C, Meng F, Xie F, Zhong Z.
    J Control Release; 2015 May 10; 205():144-54. PubMed ID: 25596560
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
    Hao T, Chen D, Liu K, Qi Y, Tian Y, Sun P, Liu Y, Li Z.
    ACS Appl Mater Interfaces; 2015 Aug 19; 7(32):18064-75. PubMed ID: 26214761
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles.
    Yu P, Yu H, Guo C, Cui Z, Chen X, Yin Q, Zhang P, Yang X, Cui H, Li Y.
    Acta Biomater; 2015 Mar 19; 14():115-24. PubMed ID: 25498306
    [Abstract] [Full Text] [Related]

  • 11. Tumor acidity activated triphenylphosphonium-based mitochondrial targeting nanocarriers for overcoming drug resistance of cancer therapy.
    Yu H, Li JM, Deng K, Zhou W, Wang CX, Wang Q, Li KH, Zhao HY, Huang SW.
    Theranostics; 2019 Mar 19; 9(23):7033-7050. PubMed ID: 31660085
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin.
    Qiu L, Qiao M, Chen Q, Tian C, Long M, Wang M, Li Z, Hu W, Li G, Cheng L, Cheng L, Hu H, Zhao X, Chen D.
    Biomaterials; 2014 Dec 19; 35(37):9877-9887. PubMed ID: 25201738
    [Abstract] [Full Text] [Related]

  • 14. The effect of dual-functional hyaluronic acid-vitamin E succinate micelles on targeting delivery of doxorubicin.
    Wang J, Ma W, Guo Q, Li Y, Hu Z, Zhu Z, Wang X, Zhao Y, Chai X, Tu P.
    Int J Nanomedicine; 2016 Dec 19; 11():5851-5870. PubMed ID: 27853369
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Breast cancer targeted chemotherapy based on doxorubicin-loaded bombesin peptide modified nanocarriers.
    Wang C, Sun X, Wang K, Wang Y, Yang F, Wang H.
    Drug Deliv; 2016 Oct 19; 23(8):2697-2702. PubMed ID: 26203692
    [Abstract] [Full Text] [Related]

  • 17. Robust, active tumor-targeting and fast bioresponsive anticancer nanotherapeutics based on natural endogenous materials.
    Sun B, Deng C, Meng F, Zhang J, Zhong Z.
    Acta Biomater; 2016 Nov 19; 45():223-233. PubMed ID: 27576338
    [Abstract] [Full Text] [Related]

  • 18. Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy.
    Guo XL, Kang XX, Wang YQ, Zhang XJ, Li CJ, Liu Y, Du LB.
    Acta Biomater; 2019 Jan 15; 84():367-377. PubMed ID: 30528609
    [Abstract] [Full Text] [Related]

  • 19. A glutathione-responsive sulfur dioxide polymer prodrug as a nanocarrier for combating drug-resistance in cancer chemotherapy.
    Shen W, Liu W, Yang H, Zhang P, Xiao C, Chen X.
    Biomaterials; 2018 Sep 15; 178():706-719. PubMed ID: 29433753
    [Abstract] [Full Text] [Related]

  • 20. Investigation on vitamin e succinate based intelligent hyaluronic acid micelles for overcoming drug resistance and enhancing anticancer efficacy.
    Hou L, Tian C, Chen D, Yuan Y, Yan Y, Huang Q, Zhang H, Zhang Z.
    Eur J Pharm Sci; 2019 Dec 01; 140():105071. PubMed ID: 31525433
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.